Abstract
Prostate cryoablation was introduced in the clinical practice in 1995. Thanks to the intraoperative ultrasound imaging control, it was among the first treatment echo-guided approach in urology. The role of ultrasound is essential both for verifying the positioning of cryoprobes and for monitoring the freezing phases. The liquid nitrogen, used by the first-generation machines, was then replaced by argon (an inert gas), which is based on the Joule-Thomson effect in the modern cryoprobes. The argon in the transition – from liquid to gaseous – allows to reach temperatures of −180 °C in a very short time.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heidenreich A, Bastian PJ, Bellmunt J et al; European Association of Urology (2014) EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65(1):124–137.
Wenske S, Quarrier S, Katz AE (2013) Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol 64(1):1–7
Caso JR, Tsivian M, Mouraviev V, Polascik TJ (2012) Predicting biopsy-proven prostate cancer recurrence following cryosurgery. Urol Oncol 30(4):391–395
Levy DA, Jones JS (2011) Impact of prostate gland volume on cryoablation prostate-specific antigen outcomes. Urology 77(4):994–998
Grossgold E, Given R, Ruckle H, Jones JS (2014) Does neoadjuvant androgen deprivation therapy before primary whole gland cryoablation of the prostate affect the outcome? Urology 83(2):379–383
Ullal AV, Korets R, Katz AE, Wenske S (2013) A report on major complications and biochemical recurrence after primary and salvage cryosurgery for prostate cancer in patients with prior resection for benign prostatic hyperplasia: a single-center experience. Urology 82(3):648–652
Ukimura O, de Castro Abreu AL, Hung AJ, Gill IS (2014) Cryosurgery for clinical T3 prostate cancer. BJU Int 113(5):684–685
Sverrisson EF, Nguyen H, Kim T, Pow-Sang JM (2014) Primary cryosurgery for clinically localized prostate cancer – do perioperative tumor characteristics correlate with post-treatment biopsy results? Urology 83(2):376–378
Chin JL, Al-Zahrani AA, Autran-Gomez AM, Williams AK, Bauman G (2012) Extended follow-up oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b). J Urol 188(4):1170–1175
Minardi D, Polito M, Galosi AB et al (2000) Ultrasound-guided cryosurgery of the prostate: short- and long-term experience. Arch Ital Urol Androl 72(4):270–275
Onik G (2001) Image-guided prostate cryosurgery: state of the art. Cancer Control 8(6):522–531
Ward JF, Jones JS (2012) Focal cryoablation for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int 109(11):1648–1654
Roach M 3rd (2010) Primary focal unilateral nerve-sparing cryoablation for very early prostate cancer: is it enough or too much, or do we know? Cancer J 16(5):542–543
de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, Gill IS, Ukimura O (2013) Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int 112(3):298–307
Robilotto AT, Baust JM, Van Buskirk RG, Gage AA, Baust JG (2013) Temperature-dependent activation of differential apoptotic pathways during cryoablation in a human prostate cancer model. Prostate Cancer Prostatic Dis 16(1):41–49
Padilha MM, Stephen Jones J, Streator Smith K, Zhou M, Walker E, Magi-Galluzzi C (2013) Prediction of prostate cancer to urethra distance by a pretreatment nomogram: urethral thermoprotection implication in cryoablation. Prostate Cancer Prostatic Dis 16(4):372–375
Galosi AB, Lugnani F, Muzzonigro G (2007) Salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. J Endourol 21(1):1–7
Pitman M, Shapiro EY, Hruby GW, Truesdale MD, Cheetham PJ, Saad S, Katz AE (2012) Comparison of biochemical failure definitions for predicting local cancer recurrence following cryoablation of the prostate. Prostate 72(16):1802–1808
Galosi AB, Muzzonigro G, Polito M Jr, Minardi D, Dellabella M, Lugnani F, Polito M (2000) Role of transrectal ultrasonography in the follow-up of patients treated with prostatic cryosurgery. Arch Ital Urol Androl 72(4):276–281
Ko YH, Kang SH, Park YJ, Park HS, du Moon G, Lee JG, Yoon DK, Kim JJ, Cheon J (2010) The biochemical efficacy of primary cryoablation combined with prolonged total androgen suppression compared with radiotherapy on high-risk prostate cancer: a 3-year pilot study. Asian J Androl 12(6):827–834
Martino P, Scattoni V, Galosi AB, Consonni P, Trombetta C, Palazzo S, Maccagnano C, Liguori G, Valentino M, Battaglia M, Barozzi L (2011) Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryoablation, HIFU) Word. J Urol 29(5):595–605
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Galosi, A.B., Quaresima, L. (2017). Ultrasound Guided Treatment of Prostatic Cancer: Cryoablation. In: Martino, P., Galosi, A. (eds) Atlas of Ultrasonography in Urology, Andrology, and Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-40782-1_31
Download citation
DOI: https://doi.org/10.1007/978-3-319-40782-1_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40780-7
Online ISBN: 978-3-319-40782-1
eBook Packages: MedicineMedicine (R0)